Literature DB >> 18775038

Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality.

Ilan Goldenberg, Arthur J Moss.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18775038     DOI： 10.1111/j.1540-8167.2008.01287.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN： 1045-3873


× No keyword cloud information.
  4 in total

1.  Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation.

Authors:  Gustavo Lopera; Gerald A Beathard; Jose Exaire; Roger Carrillo
Journal:  J Interv Card Electrophysiol       Date:  2012-06       Impact factor: 1.900

Review 2.  Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.

Authors:  Yitschak Biton; Jayson R Baman; Bronislava Polonsky
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

Review 3.  Implantable cardioverter-defibrillators: indications and unresolved issues.

Authors:  Rohit Kedia; Mohammad Saeed
Journal:  Tex Heart Inst J       Date:  2012

4.  Impact of moderate to severe renal impairment on mortality and appropriate shocks in patients with implantable cardioverter defibrillators.

Authors:  Venkata M Alla; Kishlay Anand; Mandeep Hundal; Aimin Chen; Showri Karnam; Tom Hee; Claire Hunter; Aryan N Mooss; Dennis Esterbrooks; Syed M Mohiuddin
Journal:  Cardiol Res Pract       Date:  2010-12-15       Impact factor: 1.866
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.